Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Cancer Science: Drugging a Cancer-Associated Chaperone Shows Promise
Sara Hartley, MDLinx Oncology
FDA Update: Anti-CD20 Antibody Granted Accelerated Approval for CLL
Tracy Hampton, PhD, MDLinx Oncology
Congress Proposes SGR Fix
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all

Articles: Gynecologic Oncology



Latest (3) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Loss of programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
Molecular Cancer, 09/08/09    Free full text
Sponsor
The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women
International Journal of Cancer, 09/08/09
Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients
Gynecologic Oncology, 09/08/09
Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer
Gynecologic Oncology, 09/08/09
mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Clinical Cancer Research, 09/08/09
Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome
Gynecologic Oncology, 09/08/09
Brain metastasis as a late manifestation of ovarian carcinoma
European Journal of Cancer Care, 09/08/09
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Journal of Clinical Oncology, 09/04/09
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172
Gynecologic Oncology, 09/04/09
Natural history of persistent high-risk human papillomavirus infections in Korean women
Gynecologic Oncology, 09/04/09
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
The Lancet Oncology - Online First, 09/03/09
Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members
Journal of Clinical Oncology, 09/03/09
RNA splicing factors regulated by HPV16 during cervical tumour progression
The Journal of Pathology, 09/03/09
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules
Journal of Clinical Oncology, 09/02/09
Conformal Brachytherapy Planning for Cervical Cancer Using Transabdominal Ultrasound
International Journal of Radiation Oncology*Biology*Physics, 09/02/09
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results
Gynecologic Oncology, 09/02/09
Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review
Gynecologic Oncology, 09/02/09    Revew Article
Topical treatment of CIN 2+ by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study
Gynecologic Oncology, 09/02/09
Myoepithelial neoplasms involving the vulva and vagina: report of 4 cases
Human Pathology, 09/02/09
HPV infection in Europe
European Journal of Cancer, 09/02/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
First    Prev    10      11      12      13      14      15      16      17      18      19      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.